Results 61 to 70 of about 110,931 (189)

Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis

, 2017
Background/purpose: Patients with leptomeningeal carcinomatosis (LC) from breast cancer is generally resistant to systemic chemotherapy. Bevacizumab may increase intratumor concentration of the chemotherapeutic agents through vascular normalization ...
盧彥伸;林璟宏;詹一秀;陳怡君;鄭安理;林季宏, Chen, I-Chun;Lin, Ching-Hung;Jan, I-Shiow;Cheng, Ann-Lii;Lu, Yen-Shen   +1 more
core   +1 more source

Intravitreal Injection of Bevacizumab and Gas for Diabetic Premacular Hemorrhage with Active Fibrovascular Proliferation

, 2009
: Background To report the effect of intravitreal injection of bevacizumab and gas for the treatment of diabetic premacular hemorrhage with active fibrovascular proliferation.
施智偉;楊中美;陳慕師;王宗仁, SHIH, CHIH-WEI;YANG, CHUNG-MAY;CHEN, MUH-SHY;WANG, TSUNG-JEN   +1 more
core   +1 more source

Evaluation of a New Potential Bevacizumab Biosimilar in Corneal Neovascularization

Türk Oftalmoloji Dergisi
Objectives: To compare the antiangiogenic effects of bevacizumab and a new potential bevacizumab biosimilar (anti-human VEGF GU01) on suture-induced corneal neovascularization (CNV) in rabbits. Materials and Methods: CNV was induced in the right eyes of
Armağan Özgür, Nilüfer Yeşilırmak, Mehmet Arda İnan, Emin Ümit Bağrıaçık, Mehmet Cüneyt Özmen   +4 more
doaj   +1 more source

Gravity influences bevacizumab distribution in an undisturbed balanced salt solution in vitro.

PLoS ONE, 2019
PurposeThe effects of gravity on bevacizumab or the recommended head position after intraocular bevacizumab injection have not been reported. To evaluate the effect of gravity on bevacizumab in vitro, we added bevacizumab to the upper part of a test tube
Rae Young Kim, Soonil Kwon, Ho Ra
doaj   +1 more source

Efferent therapy in the first-line drug treatment of metastatic colorectal cancer

Медицинский совет, 2018
The aim of this study is to analyse the efficacy of efferent therapy (hemosorption) as part of drug treatment in patients with metastatic colorectal cancer (mCRC) based on the use of standard first-line chemotherapy combined with the bevacizumab ...
Z. S. Kotova, T. Yu. Semiglazova, I. A. Baldueva, D. H. Latipova, D. O. Yurlov, V. V. Semiglazov, G. M. Teletaeva, A. V. Novik, A. I. Semenova, S. A. Protsenko   +9 more
doaj   +1 more source

Bevacizumab in the treatment of ovarian cancer [PDF]

, 2011
Ramez N Eskander1, Leslie M Randall21Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California Irvine Medical Center, Orange, CA, USA; 2Division of Gynecologic Oncology, Department of Obstetrics and Gynecology ...
Leslie Randall, Eskander, Ramez N, Randall, Leslie M, Ramez N Eskander, Leslie M Randall   +4 more
core   +1 more source

Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer

Cancer Medicine, 2019
Purpose Combination of biological therapy and chemotherapy improves the survival of patients with metastatic colorectal cancer (mCRC). However, the optimal biological therapy sequence remains unclear.
Hung‐Chih Hsu, Yu‐Chun Liu, Chuang‐Wei Wang, Wen-Chi Chou, Yu-Jen Hsu, Jy-Ming Chiang, Yung-Chang Lin, Tsai-Sheng Yang   +7 more
doaj   +1 more source

Neoadjuvant bevacizumab and chemoradiotherapy in locally advanced rectal cancer: early outcome and technical impact on toxicity

, 2017
Background: We aimed to evaluate early clinical and pathological results for treating locally advanced rectal cancer with bevacizumab and neoadjuvant concurrent chemoradiotherapy using the technique of prone-position volumetric modulated arc therapy and ...
林育麟;成佳憲;王嘉檇;陳育瑄;蔡巧琳;孫家棟;梁金銅, Wang, Chia-Chun;Liang, Jin-Tung;Tsai, Chiao-Ling;Chen, Yu-Hsuan;Lin, Yu-Lin;Shun, Chia-Tung;Cheng, Jason Chia-Hsien   +1 more
core   +1 more source

Bevacizumab in maintenance therapy for ovarian cancer patients

Южно-Российский онкологический журнал, 2020
Ovarian cancer is one of the most common cancers in women. Growth and extension of the tumor are associated with active neoangiogenesis regulated by vascular endothelial growth factor (VEGF).
L. Yu. Vladimirova, A. E. Storozhakova, E. A. Kalabanova, E. V. Verenikina, S. N. Kabanov, Ya. V. Svetitskaya, N. Yu. Samaneva, N. M. Tikhanovskaya, K. A. Novoselova, O. G. Selezneva, A. V. Tishina   +10 more
doaj   +1 more source

Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study

, 2014
Objectives: The bevacizumab/erlotinib combination was reported with high clinical activity for advanced hepatocellular carcinoma (HCC) by a phase II study conducted in the USA.
邵幼雲 ;鄭安理 ;徐志宏 ;許駿 ;孫家棟, Hsu, Chih-Hung;Kang, Yoon Koo;Yang, Tsai-Shen;Shun, Chia-Tung;Shao, Yu-Yun;Su, Wu-Chou;Sandoval-Tan, Jennifer;Chiou, Tzeon-Jye;Jin, Kate;Hsu, Chiun;Cheng, Ann-Lii   +1 more
core   +1 more source